Merck Files 12 Lawsuits Over Generic Januvia/Janumet Filings
On February 13, 2019, Merck filed 12 lawsuits in the Wilmington, Delaware Federal Court claiming patent infringement on Merck’s Januvia franchise. Defendants include Teva, Sandoz, Mylan, Watson, Zydus, Sun, Wockhardt, Macleods, Apotex, Torrent, Anchen, and Alvogen Pine Brook. Below, FENIX provides thoughts on the lawsuits and potential insight into when generic Januvia could enter the US market.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.